About the Authors
- Nikola Sprigg
-
Affiliation Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottinghamshire, United Kingdom
- Laura J. Gray
-
Affiliation Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottinghamshire, United Kingdom
- Tim England
-
Affiliation Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottinghamshire, United Kingdom
- Mark R. Willmot
-
Affiliation Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottinghamshire, United Kingdom
- Lian Zhao
-
Affiliation Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottinghamshire, United Kingdom
- Gillian M. Sare
-
Affiliation Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottinghamshire, United Kingdom
- Philip M. W. Bath
-
* E-mail: philip.bath@nottingham.ac.uk
Affiliation Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottinghamshire, United Kingdom
Competing Interests
Philip Bath has consulted for Boehringer Ingelheim and has spoken at symposia related to dipyridamole.
Author Contributions
Conceived and designed the experiments: PMWB. Performed the experiments: NS MRW LZ. Analyzed the data: LJG. Wrote the paper: NS TE PMWB. Performed blinded adjudication of adverse events: TE. Prepared adverse event summaries: GS.